Bigfoot Biomedical for More Accurate Insulin Dosing: Interview with CMO Red Maxwell

Managing insulin-dependent diabetes is no easy task. Most patients manually measure blood glucose and calculate insulin dosing using traditional multiple dose injection (MDI) therapy, a burdensome process that puts them at risk for both hypo- and hyperglycemia. Bigfoot Biomedical is working on a solution to take the guesswork out of MDI.


This is a companion discussion topic for the original entry at https://www.medgadget.com/2020/03/bigfoot-biomedical-for-more-accurate-insulin-dosing-interview-with-cmo-red-maxwell.html